Hepatic soluble epoxide hydrolase A promising target for unveiling the liver-brain axis in Alzheimer's disease

被引：1
|
作者：
Inoue, Yasuteru [1 ]
Bamkole, Michael [1 ]
Kanekiyo, Takahisa [1 ]
机构：
[1] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA
来源：
NEURON | 2023年 / 111卷 / 18期
关键词：
PATHOLOGY;
D O I：
10.1016/j.neuron.2023.08.019
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Wu and Dong et al.(1) report that hepatic soluble epoxide hydrolase (sEH) manipulation impacts amyloid-beta (A beta) deposits and cognitive impairment in mouse models for Alzheimer's disease (AD), suggesting that hepatic sEH activity is a promising therapeutic target to treat AD.
引用
收藏
页码：2775 / 2777
页数：3
相关论文
共 50 条
  • [41] Epitranscriptomic alterations due to soluble epoxide hydrolase inhibition in experimental alcohol-associated liver disease
    Warner, J. B.
    Song, Y. L.
    Hardesty, J. E.
    McClain, C. J.
    Jebet, A.
    Liqing, H.
    Zhang, X.
    Warner, D. R.
    Kirpich, I. A.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 : 504 - 505
  • [42] Liver-brain axis in alcoholic liver disease: Chronic alcohol induces recruitment of peripheral macrophages with different inflammatory gene expression profile into the liver and brain
    Lowe, Patrick P.
    Ambade, Aditya
    Iracheta-Vellve, Arvin
    Furi, Istvan
    Gyongyosi, Benedek
    Catalano, Donna
    Kodys, Karen
    Coban, Sahin
    Lefebvre, Eric
    Szabo, Gyongyi
    HEPATOLOGY, 2017, 66 : 690A - 690A
  • [43] Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson's Disease: A New Therapeutic Strategy
    Pallas, Merce
    Vazquez, Santiago
    Sanfeliu, Coral
    Galdeano, Carles
    Grinan-Ferre, Christian
    BIOMOLECULES, 2020, 10 (05)
  • [44] Unraveling the Liver-Brain Axis: Resveratrol's Modulation of Key Enzymes in Stress-Related Anxiety
    Tseilikman, Vadim E.
    Tseilikman, Olga B.
    Shevyrin, Vadim A.
    Yegorov, Oleg N.
    Epitashvili, Alexandr A.
    Aristov, Maxim R.
    Karpenko, Marina N.
    Lipatov, Ilya A.
    Pashkov, Anton A.
    Shamshurin, Maxim V.
    Buksha, Irina A.
    Shonina, Anna K.
    Kolesnikova, Alexandra
    Shatilov, Vladislav A.
    Zhukov, Maxim S.
    Novak, Jurica
    BIOMEDICINES, 2024, 12 (09)
  • [45] The case for soluble Aβ oligomers as a drug target in Alzheimer's disease
    Hefti, Franz
    Goure, William F.
    Jerecic, Jasna
    Iverson, Kent S.
    Walicke, Patricia A.
    Krafft, Grant A.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2013, 34 (05) : 261 - 266
  • [46] Soluble oligomers of Aβ as a key therapeutic target for Alzheimer's disease
    Selkoe, Dennis
    NEUROBIOLOGY OF AGING, 2008, 29 : S21 - S22
  • [47] GENETIC ABLATION OR PHARMACOLOGICAL INHIBITION OF SOLUBLE EPOXIDE HYDROLASE ATTENUATED LIVER INJURY AND INFLAMMATION IN MOUSE MODELS OF ALCOHOLIC LIVER DISEASE
    Warner, Jeffrey
    Song, Ying
    Warner, Dennis
    Hardesty, Josiah
    McClain, Craig J.
    Kirpich, Irina A.
    HEPATOLOGY, 2019, 70 : 841A - 842A
  • [48] Slow Wave Sleep Is a Promising Intervention Target for Alzheimer's Disease
    Lee, Yee Fun
    Gerashchenko, Dmitry
    Timofeev, Igor
    Bacskai, Brian J.
    Kastanenka, Ksenia V.
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [49] Cisd2: a promising new target in Alzheimer's disease†
    Nobili, Annalisa
    Krashia, Paraskevi
    D'Amelio, Marcello
    JOURNAL OF PATHOLOGY, 2020, 251 (02): : 113 - 116
  • [50] Sirtuin Proteins and Memory: A Promising Target in Alzheimer's Disease Therapy?
    Fernandez, Francesca
    Griffiths, Lyn R.
    Sutherland, Heidi G.
    Cole, Michael H.
    Fitton, J. Helen
    Winberg, Pia
    Schweitzer, Daniel
    Hopkins, Lloyd N.
    Meyer, Barbara J.
    NUTRIENTS, 2024, 16 (23)
12345